Clinical Trials Directory

Trials / Terminated

TerminatedNCT00872547

Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Resurfacing and Primary Total Hip Replacement

Prospective, International Multi-centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-term Performance of a Large Metal-on-Metal (MoM) Bearing Comprising a DePuy ASR™ Cup in Conjunction With Either a DePuy ASR™ Hip Resurfacing Femoral Component or a DePuy ASR™ XL Head in Subjects With Indications Suitable for Either a Primary Resurfacing Arthroplasty or Primary Total Hip Arthroplasty

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
329 (actual)
Sponsor
DePuy International · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to monitor the performance of a large metal-on-metal bearing from the DePuy ASR™ System in the treatment of patients with hip joint disease requiring hip resurfacing surgery or a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments. The Study was terminated with effect from 30th November 2011 following the completion of 2 year follow up assessments for those patients remaining in the study. Please note that prior to this decision DePuy voluntarily recalled the ASR products on 24 August 2010. Additional information regarding this voluntary recall and the follow-up of patients affected by the recall can be found at the following links http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON155761 and http://www.depuy.com/countries\_list.

Conditions

Interventions

TypeNameDescription
DEVICEDePuy ASR™ Hip SystemResurfacing system
DEVICEDePuy ASR™ XL Head / ASR™ Acetabular Cup SystemLarge Metal-on-Metal Total Hip Replacement

Timeline

Start date
2006-09-01
Primary completion
2011-11-01
Completion
2011-11-01
First posted
2009-03-31
Last updated
2016-08-04

Locations

8 sites across 8 countries: Austria, Czechia, Finland, Germany, Norway, Portugal, Switzerland, United Kingdom

Source: ClinicalTrials.gov record NCT00872547. Inclusion in this directory is not an endorsement.